Med-El Hears From FDA: Cochlear Implant Firm Cited for QSR Deficiencies
This article was originally published in The Gray Sheet
Executive Summary
Med-El plans to submit a response to FDA addressing issues raised in a Nov. 16 warning letter citing the cochlear implant manufacturer for quality system regulation violations